_id

690da983ccc777a4e85d0855

Ticker

ADAP

Name

Adaptimmune Therapeutics Plc

Exchange

NASDAQ

Address

60 Jubilee Avenue, Abingdon, United Kingdom, OX14 4RX

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.adaptimmune.com

Description

Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA ((famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the treatment of head and neck cancer. The company also focuses on the development of T-cell therapies directed to PRAME (ADP-600) and CD70 (ADP-520). It has strategic collaboration with Galapagos to clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel produced on Galapagos' decentralized manufacturing platform (ADP-5701) in patients with head and neck cancer; collaboration and license agreement with Noile-Immune Biotech, Inc. and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.

Last Close

0.033

Volume

9315465

Current Price

0.052

Change

0.016

Last Updated

2025-11-18T08:34:41.002Z

Image

-

Ipo Date

2015-05-06T00:00:00.000Z

Market Cap

14551333

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.993

Sentiment Sources

1

Rating

3.7778

Target Price

0.6833

Strong Buy

3

Buy

2

Hold

3

Sell

1

Strong Sell

0

Current Quarter

2025-06-30

Revenue

13677000

Cost Of Revenue

2501000

Gross Profit

11176000

Operating Expenses

41464000

Operating Income

-30288000

Interest Expense

962000

Pretax Income

-29728000

Net Income

-30340000

Eps

-0.11488631905956649

Dividends Per Share

-

Shares Outstanding

264087145

Income Tax Expense

612000

EBITDA

-26257000

Operating Margin

-221.45207282298747

Total Other Income Expense Net

-

Cash

26061000

Short Term Investments

0

Receivables

28895000

Inventories

11411000

Total Current Assets

78115000

Property Plant Equipment

46900000

Total Assets

130633000

Payables

9418000

Short Term Debt

9028000

Long Term Debt

25675000

Total Liabilities

201591000

Equity

-70958000

Depreciation

2509000

Change In Working Capital

-7723000

Cash From Operations

-34780000

Capital Expenditures

75000

Cash From Investing

18490000

Cash From Financing

1654000

Net Change In Cash

-15226000

PE

-

PB

-0.1935304199667409

ROE

42.757687646213256

ROA

-23.225371843255534

FCF

-34855000

Fcf Percent

-2.548438985157564

Piotroski FScore

0

Health Score

30

Deep Value Investing Score

2.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

6.8

Garp Investing Score

4.5

Growth Investing Score

4.5

Momentum Investing Score

5.5

Net Net Investing Score

2

Quality Investing Score

3

Value Investing Score

3

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

13677000

Quarters > 0 > income Statement > cost Of Revenue

2501000

Quarters > 0 > income Statement > gross Profit

11176000

Quarters > 0 > income Statement > operating Expenses

41464000

Quarters > 0 > income Statement > operating Income

-30288000

Quarters > 0 > income Statement > interest Expense

962000

Quarters > 0 > income Statement > pretax Income

-29728000

Quarters > 0 > income Statement > net Income

-30340000

Quarters > 0 > income Statement > eps

-0.11488631905956649

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

264087145

Quarters > 0 > income Statement > income Tax Expense

612000

Quarters > 0 > income Statement > EBITDA

-26257000

Quarters > 0 > income Statement > operating Margin

-221.45207282298747

Quarters > 0 > income Statement > total Other Income Expense Net

-

Quarters > 0 > balance Sheet > cash

26061000

Quarters > 0 > balance Sheet > short Term Investments

0

Quarters > 0 > balance Sheet > receivables

28895000

Quarters > 0 > balance Sheet > inventories

11411000

Quarters > 0 > balance Sheet > total Current Assets

78115000

Quarters > 0 > balance Sheet > property Plant Equipment

46900000

Quarters > 0 > balance Sheet > total Assets

130633000

Quarters > 0 > balance Sheet > payables

9418000

Quarters > 0 > balance Sheet > short Term Debt

9028000

Quarters > 0 > balance Sheet > long Term Debt

25675000

Quarters > 0 > balance Sheet > total Liabilities

201591000

Quarters > 0 > balance Sheet > equity

-70958000

Quarters > 0 > cash Flow > net Income

-30340000

Quarters > 0 > cash Flow > depreciation

2509000

Quarters > 0 > cash Flow > change In Working Capital

-7723000

Quarters > 0 > cash Flow > cash From Operations

-34780000

Quarters > 0 > cash Flow > capital Expenditures

75000

Quarters > 0 > cash Flow > cash From Investing

18490000

Quarters > 0 > cash Flow > cash From Financing

1654000

Quarters > 0 > cash Flow > net Change In Cash

-15226000

Quarters > 0 > ratios > PE

-0.11488631905956649

Quarters > 0 > ratios > PB

-0.1935304199667409

Quarters > 0 > ratios > ROE

42.757687646213256

Quarters > 0 > ratios > ROA

-23.225371843255534

Quarters > 0 > ratios > FCF

-34855000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-2.548438985157564

Quarters > 0 > health Score

30

Quarters > 1 > quarter

2025-03-31

Quarters > 1 > income Statement > revenue

7285000

Quarters > 1 > income Statement > cost Of Revenue

879000

Quarters > 1 > income Statement > gross Profit

6406000

Quarters > 1 > income Statement > operating Expenses

52139000

Quarters > 1 > income Statement > operating Income

-45733000

Quarters > 1 > income Statement > interest Expense

1881000

Quarters > 1 > income Statement > pretax Income

-47009000

Quarters > 1 > income Statement > net Income

-47584000

Quarters > 1 > income Statement > eps

-0.18513258722872356

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

257026603

Quarters > 1 > income Statement > income Tax Expense

575000

Quarters > 1 > income Statement > EBITDA

-42662000

Quarters > 1 > income Statement > operating Margin

-627.7693891557996

Quarters > 1 > income Statement > total Other Income Expense Net

-

Quarters > 1 > balance Sheet > cash

41054000

Quarters > 1 > balance Sheet > short Term Investments

18509000

Quarters > 1 > balance Sheet > receivables

20852000

Quarters > 1 > balance Sheet > inventories

11759000

Quarters > 1 > balance Sheet > total Current Assets

102998000

Quarters > 1 > balance Sheet > property Plant Equipment

48941000

Quarters > 1 > balance Sheet > total Assets

158072000

Quarters > 1 > balance Sheet > payables

5701000

Quarters > 1 > balance Sheet > short Term Debt

9254000

Quarters > 1 > balance Sheet > long Term Debt

25411000

Quarters > 1 > balance Sheet > total Liabilities

195501000

Quarters > 1 > balance Sheet > equity

-37429000

Quarters > 1 > cash Flow > net Income

-47584000

Quarters > 1 > cash Flow > depreciation

2466000

Quarters > 1 > cash Flow > change In Working Capital

-21349000

Quarters > 1 > cash Flow > cash From Operations

-66592000

Quarters > 1 > cash Flow > capital Expenditures

1203000

Quarters > 1 > cash Flow > cash From Investing

41154000

Quarters > 1 > cash Flow > cash From Financing

-25320000

Quarters > 1 > cash Flow > net Change In Cash

-50202000

Quarters > 1 > ratios > PE

-0.18513258722872356

Quarters > 1 > ratios > PB

-0.3570863062331347

Quarters > 1 > ratios > ROE

127.13136872478559

Quarters > 1 > ratios > ROA

-30.1027379928134

Quarters > 1 > ratios > FCF

-67795000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-9.306108442004119

Quarters > 1 > health Score

30

Quarters > 2 > quarter

2024-12-31

Quarters > 2 > income Statement > revenue

3222000

Quarters > 2 > income Statement > cost Of Revenue

2907940

Quarters > 2 > income Statement > gross Profit

3222000

Quarters > 2 > income Statement > operating Expenses

76741000

Quarters > 2 > income Statement > operating Income

-73519000

Quarters > 2 > income Statement > interest Expense

1713000

Quarters > 2 > income Statement > pretax Income

-70217857

Quarters > 2 > income Statement > net Income

-74215000

Quarters > 2 > income Statement > eps

-0.28996773373933116

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

255942270

Quarters > 2 > income Statement > income Tax Expense

-1282992

Quarters > 2 > income Statement > EBITDA

-67974000

Quarters > 2 > income Statement > operating Margin

-2281.7815021725637

Quarters > 2 > income Statement > total Other Income Expense Net

-

Quarters > 2 > balance Sheet > cash

91139000

Quarters > 2 > balance Sheet > short Term Investments

60466000

Quarters > 2 > balance Sheet > receivables

15982000

Quarters > 2 > balance Sheet > inventories

7320000

Quarters > 2 > balance Sheet > total Current Assets

188169000

Quarters > 2 > balance Sheet > property Plant Equipment

51218000

Quarters > 2 > balance Sheet > total Assets

245963000

Quarters > 2 > balance Sheet > payables

8692000

Quarters > 2 > balance Sheet > short Term Debt

9418000

Quarters > 2 > balance Sheet > long Term Debt

50237000

Quarters > 2 > balance Sheet > total Liabilities

234114000

Quarters > 2 > balance Sheet > equity

11849000

Quarters > 2 > cash Flow > net Income

-70814000

Quarters > 2 > cash Flow > depreciation

2835000

Quarters > 2 > cash Flow > change In Working Capital

25545000

Quarters > 2 > cash Flow > cash From Operations

-34204000

Quarters > 2 > cash Flow > capital Expenditures

1173000

Quarters > 2 > cash Flow > cash From Investing

8167000

Quarters > 2 > cash Flow > cash From Financing

1000

Quarters > 2 > cash Flow > net Change In Cash

-26216000

Quarters > 2 > ratios > PE

-0.28996773373933116

Quarters > 2 > ratios > PB

1.1232169837117056

Quarters > 2 > ratios > ROE

-626.3397755084817

Quarters > 2 > ratios > ROA

-30.17323743815127

Quarters > 2 > ratios > FCF

-35377000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-10.979826194909993

Quarters > 2 > health Score

17

Quarters > 3 > quarter

2024-09-30

Quarters > 3 > income Statement > revenue

40901000

Quarters > 3 > income Statement > cost Of Revenue

2846901

Quarters > 3 > income Statement > gross Profit

40901000

Quarters > 3 > income Statement > operating Expenses

55581000

Quarters > 3 > income Statement > operating Income

-14680000

Quarters > 3 > income Statement > interest Expense

1109000

Quarters > 3 > income Statement > pretax Income

-16786000

Quarters > 3 > income Statement > net Income

-17617000

Quarters > 3 > income Statement > eps

-0.06887855946386871

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

255768996

Quarters > 3 > income Statement > income Tax Expense

831000

Quarters > 3 > income Statement > EBITDA

-12859000

Quarters > 3 > income Statement > operating Margin

-35.891542994058824

Quarters > 3 > income Statement > total Other Income Expense Net

-

Quarters > 3 > balance Sheet > cash

116741000

Quarters > 3 > balance Sheet > short Term Investments

69349000

Quarters > 3 > balance Sheet > receivables

38614000

Quarters > 3 > balance Sheet > inventories

1874000

Quarters > 3 > balance Sheet > total Current Assets

244214000

Quarters > 3 > balance Sheet > property Plant Equipment

65290000

Quarters > 3 > balance Sheet > total Assets

317436000

Quarters > 3 > balance Sheet > payables

9069000

Quarters > 3 > balance Sheet > short Term Debt

8350000

Quarters > 3 > balance Sheet > long Term Debt

49865000

Quarters > 3 > balance Sheet > total Liabilities

237447000

Quarters > 3 > balance Sheet > equity

79989000

Quarters > 3 > cash Flow > net Income

-17617000

Quarters > 3 > cash Flow > depreciation

2818000

Quarters > 3 > cash Flow > change In Working Capital

-45529000

Quarters > 3 > cash Flow > cash From Operations

-54451000

Quarters > 3 > cash Flow > capital Expenditures

435000

Quarters > 3 > cash Flow > cash From Investing

-66018000

Quarters > 3 > cash Flow > cash From Financing

25001000

Quarters > 3 > cash Flow > net Change In Cash

-95254000

Quarters > 3 > ratios > PE

-0.06887855946386871

Quarters > 3 > ratios > PB

0.1662727098976109

Quarters > 3 > ratios > ROE

-22.024278338271515

Quarters > 3 > ratios > ROA

-5.549780113156668

Quarters > 3 > ratios > FCF

-54886000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-1.3419231803623384

Quarters > 3 > health Score

19

Valuation > metrics > PE

-0.11488631905956649

Valuation > metrics > PB

-0.1935304199667409

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

42.757687646213256

Profitability > metrics > ROA

-38.84017154195737

Profitability > metrics > Net Margin

-2.2183227315931857

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-31.484407484407484

Risk > final Score

-96

Risk > verdict

High

Liquidity > metrics > Current Ratio

4.234793451154722

Liquidity > metrics > Quick Ratio

3.6161769489320177

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

80

Prev Valuations > 2

70

Prev Profitabilities > 0

40

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-67

Prev Risks > 1

-166

Prev Risks > 2

-35

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T21:19:56.483Z